Delivery Order SPE2DB22D2206-SPE2DB25FHY14
- Not listed
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $7,002.40 contract is for the delivery of Biktarvy 50-200-25 mg tablets to support military treatment programs and facilities. The delivery order is part of a larger $999,999,999.00 indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, which serves as...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a major pharmaceutical distributor, to provide Biktarvy 50-200-25 mg tablets. The $15,512.03 firm fixed-price contract has a completion date of June 21, 2024 and is not set aside for any special category of business. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide...
- The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order contract valued at $38,888.67 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of Biktarvy 50-200-25 mg tablets. This order is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to DLA...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $10,319.82, is for the delivery of Biktarvy 50-200-25 mg tablets. There is no set-aside designation, indicating this was an open competition. The contract has an ultimate completion date of April 24, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) has awarded a Delivery Order contract to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, a major pharmaceutical distributor. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a prescription medication, with a ceiling value of $12,630.54 and a completion date of June 12, 2024. This order is placed under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a Firm Fixed Price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $15,690.18, is for the provision of Biktarvy 50-200-25 mg tablet, a medication used in the treatment of HIV. The contract has an ultimate completion date of January 22, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $12,022.25 delivery order contract is for the supply of Biktarvy 50-200-25 mg tablets, a prescription medication, with a period of performance through April 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a significant $999,999,999.00...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The $11,161.86 firm fixed-price contract has an ultimate completion date of August 27, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025 for a comprehensive range of medical commodities to...
- This is a $31,892.68 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Biktarvy 50-200-25 mg tablets, a medication used to treat HIV. The contract has an ultimate completion date of April 17, 2025 and is not a set-aside. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,457.63 contract is for the supply of Biktarvy 50-200-25 mg tablet in 30-count packages. The contract has a period of performance through May 6, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a $999,999,999.00 Indefinite Delivery...
- SPE2DB22D2206Indefinite Delivery Contract
- SPE2DB22D2206-SPE2DB25FHY14Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded a $23,243.32 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Biktarvy 50-200-25 mg tablets. The contract has an ultimate completion date of July 18, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp, a for-profit organization, holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle. This delivery order contract supports the DLA's procurement of critical medical commodities, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains for military healthcare programs.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $23.2k | 7/17/25 |